Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jessica R. Hoag"'
Autor:
Jenerius A. Aminawung, Jessica R. Hoag, Kelly A. Kyanko, Xiao Xu, Ilana B. Richman, Susan H. Busch, Cary P. Gross
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5662-5671 (2020)
Abstract Background Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. Methods We surveyed in March
Externí odkaz:
https://doaj.org/article/fa6bb5c0f85d4bfcad9c21df28e1b226
Autor:
Xiao Xu, Susan H. Busch, Jenerius A. Aminawung, Jessica R. Hoag, Kelly A. Kyanko, Cary P. Gross, Ilana B. Richman
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5662-5671 (2020)
Cancer Medicine
Cancer Medicine
Background Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. Methods We surveyed in March–April 20
Autor:
Jessica R. Hoag, Ilana B. Richman, Xiao Xu, Jenerius A. Aminawung, Cary P. Gross, Kelly A. Kyanko, Susan H. Busch
Publikováno v:
Journal of General Internal Medicine. 35:1940-1945
To date, 38 states have enacted dense breast notification (DBN) laws mandating that mammogram reports include language informing women of risks related to dense breast tissue. Nationally representative survey to assess the association between residin
Autor:
Kelly A. Kyanko, Cary P. Gross, Susan H. Busch, Jessica R. Hoag, Jenerius A. Aminawung, Mia Djulbegovic, Xiao Xu
Publikováno v:
J Gen Intern Med
Autor:
Amy J. Davidoff, Jessica R. Hoag, Steven D. Gore, Amer M. Zeidan, Xiaomei Ma, Rong Wang, Scott F. Huntington, Smith Giri, Cary P. Gross
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:1194-1202
Background: Provider experience, or clinical volume, is associated with improved outcomes in many complex healthcare settings. Despite increased complexity of anticancer therapies, studies evaluating physician-level experience and cancer treatment ou
Autor:
Michelle C. Salazar, Andres F. Monsalve, Frank C. Detterbeck, Cary P. Gross, Jessica R. Hoag, Justin D. Blasberg, Alexander S. Chiu, Brian N. Arnold, Jeph Herrin, Daniel J. Boffa, Raymond A. Jean, Clara H. Kim
Publikováno v:
Annals of Surgery. 270:281-287
OBJECTIVE To estimate the potential mortality reduction if patients chose the safest hospitals for complex cancer surgery. BACKGROUND Mortality after complex oncologic surgery is highly variable across hospitals, and directing patients away from unsa
Autor:
Andrew P. Dhanasopon, Andres F. Monsalve, Alexander S. Chiu, Daniel J. Boffa, Justin D. Blasberg, Jessica R. Hoag, Benjamin J. Resio
Publikováno v:
Journal of Thoracic Disease. 11:811-818
Background: Brain metastases are a major cause of mortality in patients with small cell lung cancer (SCLC). Prophylactic cranial irradiation (PCI) may improve survival among patients that respond to chemotherapy. Less is known about the outcomes of P
Autor:
Lawrence B. Brown, Justin D. Blasberg, Daniel J. Boffa, Benjamin J. Resio, Jessica R. Hoag, Andres F. Monsalve, Alexander S. Chiu, Frank C. Detterbeck
Publikováno v:
Lung Cancer. 127:130-137
Non-Small Cell Lung Cancer (NSCLC) is commonly diagnosed in patients who have survived a prior malignancy. However, it is currently unclear whether NSCLC patient survival is impacted by the potential for previously-treated malignancies to recur. Unde
Autor:
Regina J. Hooley, Susan H. Busch, Jessica R. Hoag, Cary P. Gross, Akhil Upneja, Jessica B. Long, Ilana B. Richman, Kelly A. Kyanko, Xiao Xu, Natalia Kunst, Jenerius A. Aminawung
Publikováno v:
J Natl Cancer Inst
Background Digital breast tomosynthesis (DBT) may have a higher cancer detection rate and lower recall compared with 2-dimensional (2 D) mammography for breast cancer screening. The goal of this study was to evaluate screening outcomes with DBT in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568fdd1a9e9361ef94497e16b6f71753
https://europepmc.org/articles/PMC8757313/
https://europepmc.org/articles/PMC8757313/
Autor:
Jessica R. Hoag, Jeph Herrin, Theresa Ermer, Marianna V. Papageorge, Sarah B. Goldberg, Michelle C. Salazar, Daniel J. Boffa, Maureen E. Canavan, Ranjan Pathak
Publikováno v:
JAMA Oncol
Importance Tumor size larger than 4 cm is accepted as an indication for adjuvant chemotherapy in patients with node-negative non-small cell lung cancer (NSCLC). Treatment guidelines suggest that high-risk features are also associated with the efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a554bf8674b4c8a37d6cf3569b12a27
https://europepmc.org/articles/PMC7499246/
https://europepmc.org/articles/PMC7499246/